Anxiety Level, Symptom Burden Linked in Gynecologic Cancers
Researchers described distinct anxiety profiles and identified clinical characteristics of each one.
Diagnosis & Disease Information
Engaging Patients to Improve Genetic Risk Assessment and Testing
Preliminary results of a study comparing outreach methods for engaging patients in genetic risk assessment and testing are presented.
Validation of Nursing Skills Improves Central Line Infection Rates on HSCT Unit
A project to reverse an increase in CLABSIs on an HSCT inpatient unit and its ongoing impact were described at the Annual ONS Congress.
Overcoming Pandemic-Based Barriers to Nutritional Risk Assessment of Patients
An internal focus group produced a process to overcome the barriers to nutritional risk assessment of patients with cancer.
Addressing Fertility Risks and Preservation in Adolescent and Young Adult Patients With Cancer
The interventions developed to address barriers to fertility discussions with AYA patients at a major cancer center are described.
Coordinating Intravenous Site Selection for Same-Day Imaging and Chemotherapy
A team of nurses sought to improve coordination of care regarding choice of insertion site for peripheral intravenous catheters in patients undergoing same-day imaging and chemotherapy.
Task Force Improves Mediport Infection Rates in Ambulatory Patients With Cancer
A plan for reducing mediport infections in ambulatory patients was described at the 2022 ONS Congress.
Colorectal Cancer Treatment Has Long-Term Cognitive, Functional Effects on Survivors
Researchers sought to confirm several hypotheses regarding long-term effects of treatment in patients with colorectal cancer.
Health-Promoting Behaviors: A Measure of Caregiver Burden in the Cancer Setting
Researchers sought to classify health-promoting behavior levels among family caregivers of patients with cancer and to identify risk factors for low levels.
SOP for Successful Administration of Immune Effector Cell Therapy
An SOP for the administration of investigational immune effector cell therapy was established and presented at ONS Congress 2022.
- Loading...
Loading...
Next post in ONS Annual Congress 2022
Loading... 
Loading...